Brind.

Baird and Wells Fargo questioned Exact Sciences regarding revenue guidance drivers, sales expenses, and blood-based screening data timelines.

1 report, 0 independent Updated Jun 26

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Baird Exact Sciences Wells Fargo

Keep exploring

The entities involved

Baird
financial services provider

Nothing else this week.
Exact Sciences
American company in Madison, United States
- Zacks Investment Research provided stock analysis and ratings for Exact Sciences.Sun 06:59
Wells Fargo
American multinational banking and financial services company
- Wells Fargo upgraded Sweetgreen stock to overweight from equal weight on September 28, 2026.Mon 16:33
- Capital Research Global Investors acquired and increased its stake in Wells Fargo stock on June 19, 2026.Mon 16:28

Coverage

Newest first; wire copies grouped

Jun 26Unknown outlet